A constant-factor approximation algorithm for the k-median problem
Journal of Computer and System Sciences - STOC 1999
Algorithms for rational vaccine design
Algorithms for rational vaccine design
A binary variable model for affinity propagation
Neural Computation
Cancer profiles by affinity propagation
International Journal of Knowledge Engineering and Soft Data Paradigms
Link prediction of multimedia social network via unsupervised face recognition
MM '09 Proceedings of the 17th ACM international conference on Multimedia
On Graph-Based Name Disambiguation
Journal of Data and Information Quality (JDIQ)
What is a "Musical World"? An affinity propagation approach
MIRUM '11 Proceedings of the 1st international ACM workshop on Music information retrieval with user-centered and multimodal strategies
Hi-index | 0.01 |
A key problem of interest to biologists and medical researchers is the selection of a subset of queries or treatments that provide maximum utility for a population of targets. For example, when studying how gene deletion mutants respond to each of thousands of drugs, it is desirable to identify a small subset of genes that nearly uniquely define a drug 'footprint' that provides maximum predictability about the organism's response to the drugs. As another example, when designing a cocktail of HIV genome sequences to be used as a vaccine, it is desirable to identify a small number of sequences that provide maximum immunological protection to a specified population of recipients. We refer to this task as 'treatment portfolio design' and formalize it as a facility location problem. Finding a treatment portfolio is NP-hard in the size of portfolio and number of targets, but a variety of greedy algorithms can be applied. We introduce a new algorithm for treatment portfolio design based on similar insights that made the recently-published affinity propagation algorithm work quite well for clustering tasks. We demonstrate this method using the two problems described above: selecting a subset of yeast genes that act as a drug-response footprint, and selecting a subset of vaccine sequences that provide maximum epitope coverage for an HIV genome population.